Ontogeny of Human Hepatic and Intestinal Transporter Gene Expression during Childhood: Age Matters

Many drugs prescribed to children are drug transporter substrates. Drug transporters are membrane-bound proteins that mediate the cellular uptake or efflux of drugs and are important to drug absorption and elimination. Very limited data are available on the effect of age on transporter expression. Our study assessed age-related gene expression of hepatic and intestinal drug transporters. Multidrug resistance protein 2 (MRP2), organic anion transporting polypeptide 1B1 (OATP1B1), and OATP1B3 expression was determined in postmortem liver samples (fetal n = 6, neonatal n = 19, infant n = 7, child n = 2, adult n = 11) and multidrug resistance 1 (MDR1) expression in 61 pediatric liver samples. Intestinal expression of MDR1, MRP2, and OATP2B1 was determined in surgical small bowel samples (neonates n = 15, infants n = 3, adults n = 14). Using real-time reverse-transcription polymerase chain reaction, we measured fetal and pediatric gene expression relative to 18S rRNA (liver) and villin (intestines), and we compared it with adults using the 2−∆∆Ct method. Hepatic expression of MRP2, OATP1B1, and OATP1B3 in all pediatric age groups was significantly lower than in adults. Hepatic MDR1 mRNA expression in fetuses, neonates, and infants was significantly lower than in adults. Neonatal intestinal expressions of MDR1 and MRP2 were comparable to those in adults. Intestinal OATP2B1 expression in neonates was significantly higher than in adults. We provide new data that show organ- and transporter-dependent differences in hepatic and intestinal drug transporter expression in an age-dependent fashion. This suggests that substrate drug absorption mediated by these transporters may be subject to age-related variation in a transporter dependent pattern.

[1]  S. Uemoto,et al.  Developmental trajectory of intestinal MDR1/ABCB1 mRNA expression in children. , 2014, British journal of clinical pharmacology.

[2]  R. Evers,et al.  Interindividual Variability in Hepatic Organic Anion-Transporting Polypeptides and P-Glycoprotein (ABCB1) Protein Expression: Quantification by Liquid Chromatography Tandem Mass Spectroscopy and Influence of Genotype, Age, and Sex , 2014, Drug Metabolism and Disposition.

[3]  T. Andersson,et al.  Impact of OATP1B1, MDR1, and CYP3A4 Expression in Liver and Intestine on Interpatient Pharmacokinetic Variability of Atorvastatin in Obese Subjects , 2013, Clinical pharmacology and therapeutics.

[4]  Yvonne S. Lin,et al.  Interindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP/ABCG2): effect of age, sex, and genotype. , 2013, Journal of pharmaceutical sciences.

[5]  S. Caritis,et al.  Hepatobiliary Disposition of 17-OHPC and Taurocholate in Fetal Human Hepatocytes: A Comparison with Adult Human Hepatocytes , 2013, Drug Metabolism and Disposition.

[6]  Mikko Niemi,et al.  Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1 , 2013, Genome Medicine.

[7]  L. Milani,et al.  DNA methylation dynamics in the hepatic CYP3A4 gene promoter. , 2012, Biochimie.

[8]  P. Sexton,et al.  Drug transporters in drug efficacy and toxicity. , 2012, Annual review of pharmacology and toxicology.

[9]  D. Tibboel,et al.  The effect of critical illness and inflammation on midazolam therapy in children* , 2012, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[10]  Ute Hofmann,et al.  DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma , 2011, Genome Medicine.

[11]  S. Wildt.  Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children , 2011 .

[12]  P. Smith,et al.  Higher clearance of micafungin in neonates compared with adults: role of age‐dependent micafungin serum binding , 2011, Biopharmaceutics & drug disposition.

[13]  O. Fardel,et al.  Regulation of drug transporter mRNA expression by interferon‐γ in primary human hepatocytes , 2011, Fundamental & clinical pharmacology.

[14]  Curtis D. Klaassen,et al.  Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation , 2010, Pharmacological Reviews.

[15]  M. Bebawy,et al.  Dietary nucleotide supplements in infant formula modify the expression of P-glycoprotein in the intestinal epithelium in vitro. , 2009, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[16]  M. Ho,et al.  Expression of Hepatocyte Transporters and Nuclear Receptors in Children With Early and Late-Stage Biliary Atresia , 2008, Pediatric Research.

[17]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[18]  W. Kirch,et al.  Induction of Intestinal P‐glycoprotein by St John's Wort Reduces the Oral Bioavailability of Talinolol , 2007, Clinical pharmacology and therapeutics.

[19]  R. Kim,et al.  Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans , 2007, Clinical pharmacology and therapeutics.

[20]  G. Kearns,et al.  Effect of Diet on the Development of Drug Metabolism by Cytochrome P-450 Enzymes in Healthy Infants , 2006, Pediatric Research.

[21]  S. Uemoto,et al.  Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living‐donor liver transplant recipients , 2006, Clinical pharmacology and therapeutics.

[22]  M. Peuchmaur,et al.  Impact of inflammation on the duodenal mRNA expression of CYP3A and P‐glycoprotein in children with Crohn's disease , 2006, Inflammatory bowel diseases.

[23]  H. Cavé,et al.  LOCALIZATION AND mRNA EXPRESSION OF CYP3A AND P-GLYCOPROTEIN IN HUMAN DUODENUM AS A FUNCTION OF AGE , 2005, Drug Metabolism and Disposition.

[24]  W. Haefeli,et al.  Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. , 2005, Biochemical pharmacology.

[25]  A. Gaedigk,et al.  Variability of CYP3A7 Expression in Human Fetal Liver , 2005, Journal of Pharmacology and Experimental Therapeutics.

[26]  Wilhelm Kirch,et al.  Grapefruit Juice Ingestion Significantly Reduces Talinolol Bioavailability , 2005, Clinical pharmacology and therapeutics.

[27]  B. Blumberg,et al.  Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues , 2005, Molecular and Cellular Endocrinology.

[28]  M. Buyse,et al.  Influence of the pro-inflammatory cytokines on P-glycoprotein expression and functionality. , 2004, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[29]  Mei-Hwei Chang,et al.  Developmental expression of canalicular transporter genes in human liver. , 2004, Journal of hepatology.

[30]  Susan M Abdel-Rahman,et al.  Developmental pharmacology--drug disposition, action, and therapy in infants and children. , 2003, The New England journal of medicine.

[31]  W. Hop,et al.  Pharmacokinetics and metabolism of oral midazolam in preterm infants. , 2002, British journal of clinical pharmacology.

[32]  G. Tucker,et al.  Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis. , 2001, British journal of clinical pharmacology.

[33]  B. M. Forman,et al.  The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux , 2001, Nature Medicine.

[34]  G. Giaccone,et al.  Multidrug resistance gene (P-glycoprotein) expression in the human fetus. , 1992, American Journal of Pathology.

[35]  F. Guimiot,et al.  mRNA expression of MDR1 and major metabolising enzymes in human fetal tissues. , 2009, Drug metabolism and pharmacokinetics.

[36]  A. Gaedigk,et al.  Variability of CYP 3 A 7 Expression in Human Fetal Liver , 2005 .

[37]  J. Osterreicher,et al.  Expression of MRP2 and MDR1 transporters and other hepatic markers in rat and human liver and in WRL 68 cell line. , 2005, Physiological research.